In the News

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture Partners, and dRx Capital. RxVantage’s goal is to promote technology...

MM+M Podcast 1.18.22: Digital health’s funding frenzy (and what it means)

Rock Health Head of Consulting Sari Kaganoff appeared on the MM+M (Medical, Marketing + Media) podcast to unpack the numbers and interpret the directional signs behind last year’s frenzied funding environment for digital health. She said 2021 was a big year for digital health, noting...

First Venture Fund for Black-Owned Health Startups Launches with $55 Million

Health-tech startups have experienced immense success over the past two years. The need for remote care skyrocketed, and many digital health services found themselves outpacing initial growth projections as $29.1 billion was funneled into U.S. digital health startups in 2021 alone, according to Rock Health...

State of Minnesota Selects Truveris to Help Optimize Its Pharmacy Benefits Program

Program performance and pharmacy cost containment manager Truveris recently announced that the company has been selected as the exclusive oversight and procurement partner for the State of Minnesota. Together they will conduct a full reverse-auction process to guarantee the state’s pharmacy benefit needs are given...

Drugs by Drone: Good Idea?

With positive results from early tests, the drone industry is hopeful that lawmakers will increase their leniency in regulating drones. With this hope come questions about what should be considered a drone-deliverable item, specifically when it comes to controlled substances like pharmaceuticals. There are many angles...

Aetion Acquires Synthetic Data Trailblazer Replica Analytics

Regulatory-grade real-world evidence technology provider Aetion recently announced its acquisition of Replica Analytics. Replica Analytics is well known for creating synthetic health data through artificial intelligence programs. Replica will be able to help Aetion through its ability to preserve the utility of source data, thanks...